C2 single-point sampling to evaluate cyclosporine exposure in long-term renal transplant recipients
- 1 November 2001
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 33 (7-8) , 3133-3136
- https://doi.org/10.1016/s0041-1345(01)02336-3
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996New England Journal of Medicine, 2000
- LIVER ALLOTRANSPLANTATION AFTER EXTRACORPOREAL HEPATIC SUPPORT WITH TRANSGENIC (hCD55/hCD59) PORCINE LIVERSTransplantation, 2000
- NEORAL MONITORING BY SIMPLIFIED SPARSE SAMPLING AREA UNDER THE CONCENTRATION-TIME CURVETransplantation, 1999
- VARIABLE ORAL ABSORPTION OF CYCLOSPORINETransplantation, 1996
- EARLY VERSUS LATE ACUTE RENAL ALLOGRAFT REJECTIONTransplantation, 1993
- LRISK FACTORS FOR CHRONIC REJECTION IN RENAL ALLOGRAFT RECIPIENTSTransplantation, 1993
- THE RELATIONSHIP BETWEEN CYCLOSPORINE PHARMACOKINETIC PARAMETERS AND SUBSEQUENT ACUTE REJECTION IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1988
- THE MILAN CLINICAL TRIAL WITH CYCLOSPORINE IN CADAVERIC RENAL TRANSPLANTATIONTransplantation, 1988
- A Randomized Clinical Trial of Cyclosporine in Cadaveric Renal TransplantationNew England Journal of Medicine, 1986
- INDIVIDUALIZATION OF CYCLOSPORINE THERAPY USING PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERSTransplantation, 1985